BECN1 and Hyperglycemia: The inhibition of TLR4 expression improves bone metabolism, promotes ALP and bone mineralization, and reduces hyperglycemia-induced osteoblast apoptosis, levels of inflammatory factors, and the expression of Beclin 1 and LC3II/LC-I (Zhang et al., 2020).